Fig. 5

(A) Solvent Accessible Surface Area of the unbound NiV L protein, NiV L in complex with Remdesivir and NiV L in complex with Cangrelor. (B) Radius of gyration of the unbound NiV L protein, NiV L in complex with Remdesivir, and NiV L in complex with Cangrelor.